Aurora Cannabis Inc (TO:ACB) — Market Cap & Net Worth
Market Cap & Net Worth: Aurora Cannabis Inc (ACB)
Aurora Cannabis Inc (TO:ACB) has a market capitalization of $219.06 Million (CA$302.83 Million) as of September 16, 2026. Listed on the TO stock exchange, this Canada-based company holds position #16290 globally and #491 in its home market, demonstrating a -2.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aurora Cannabis Inc's stock price CA$5.34 by its total outstanding shares 56709424 (56.71 Million). Also see balance sheet size of Aurora Cannabis Inc for a full breakdown of the balance sheet.
Aurora Cannabis Inc Market Cap History: 2015 to 2026
Aurora Cannabis Inc's market capitalization history from 2015 to 2026. Data shows growth from $24.34 Million to $219.06 Million (26.36% CAGR). Also see Aurora Cannabis Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Aurora Cannabis Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aurora Cannabis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Aurora Cannabis Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.69x
Aurora Cannabis Inc's market cap is 0.69 times its annual revenue
Latest Price to Earnings (P/E) Ratio
148.78x
Aurora Cannabis Inc's market cap is 148.78 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $11.32 Billion | $1.44 Million | -$5.72 Million | 7868.15x | N/A |
| 2017 | $47.26 Billion | $18.07 Million | -$12.97 Million | 2615.72x | N/A |
| 2018 | $33.38 Billion | $55.20 Million | $71.94 Million | 604.68x | 463.97x |
| 2019 | $13.73 Billion | $245.54 Million | -$293.51 Million | 55.94x | N/A |
| 2020 | $4.35 Billion | $268.70 Million | -$3.28 Billion | 16.18x | N/A |
| 2021 | $2.81 Billion | $245.25 Million | -$693.62 Million | 11.46x | N/A |
| 2022 | $512.78 Million | $221.34 Million | -$1.72 Billion | 2.32x | N/A |
| 2023 | $266.65 Million | $233.29 Million | -$265.33 Million | 1.14x | N/A |
| 2024 | $250.65 Million | $270.28 Million | -$69.33 Million | 0.93x | N/A |
| 2025 | $236.70 Million | $343.29 Million | $1.59 Million | 0.69x | 148.78x |
Competitor Companies of ACB by Market Capitalization
Companies near Aurora Cannabis Inc in the global market cap rankings as of September 16, 2026. Review tangible equity quality of Aurora Cannabis Inc to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Aurora Cannabis Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Aurora Cannabis Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Aurora Cannabis Inc's market cap moved from $24.34 Million to $ 219.06 Million, with a yearly change of 26.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$219.06 Million | -7.45% |
| 2025 | CA$236.70 Million | -5.56% |
| 2024 | CA$250.65 Million | -6.00% |
| 2023 | CA$266.65 Million | -48.00% |
| 2022 | CA$512.78 Million | -81.75% |
| 2021 | CA$2.81 Billion | -35.38% |
| 2020 | CA$4.35 Billion | -68.34% |
| 2019 | CA$13.73 Billion | -58.85% |
| 2018 | CA$33.38 Billion | -29.38% |
| 2017 | CA$47.26 Billion | +317.39% |
| 2016 | CA$11.32 Billion | +46419.47% |
| 2015 | CA$24.34 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Aurora Cannabis Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $219.06 Million USD |
| MoneyControl | $219.06 Million USD |
| MarketWatch | $219.06 Million USD |
| marketcap.company | $219.06 Million USD |
| Reuters | $219.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more